| 1 |
Alvestad L, Jelsness-Jørgensen LP, Goll R, Clancy A, Gressnes T, Valle PC, Broderstad AR. Health-related quality of life in inflammatory bowel disease: a comparison of patients receiving nurse-led versus conventional follow-up care. BMC Health Serv Res 2022;22:1602. [PMID: 36587197 DOI: 10.1186/s12913-022-08985-1] [Reference Citation Analysis]
|
| 2 |
Kulyk A, Shafer LA, Graff LA, Stone J, Witges K, Targownik LE, Bernstein CN. Urgency for bowel movements is a highly discriminatory symptom of active disease in persons with IBD (the Manitoba Living with IBD study). Aliment Pharmacol Ther 2022;56:1570-80. [PMID: 36225106 DOI: 10.1111/apt.17241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Gatti S, Del Baldo G, Catassi G, Faragalli A, Aloi M, Bramuzzo M, D'Arcangelo G, Felici E, Fuoti M, Lega S, Panceri R, Pastore M, Penagini F, Gesuita R, Catassi C. Factors associated with quality of life in Italian children and adolescents with IBD. Sci Rep 2021;11:18076. [PMID: 34508152 DOI: 10.1038/s41598-021-97661-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
de Bock E, Filipe MD, Meij V, Oldenburg B, van Schaik FDM, Bastian OW, Fidder HF, Vriens MR, Richir MC. Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands. BMJ Open Gastroenterol 2021;8:e000670. [PMID: 34215570 DOI: 10.1136/bmjgast-2021-000670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Klages KL, Berlin KS, Cook JL, Keenan ME, Semenkovich K, Banks GG, Rybak TM, Ankney RL, Decker KM, Whitworth JR, Corkins MR. Examining Risk Factors of Health-Related Quality of Life Impairments Among Adolescents with Inflammatory Bowel Disease. Behav Med 2021;47:140-50. [PMID: 34048329 DOI: 10.1080/08964289.2019.1676193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Gioxari A, Amerikanou C, Papada E, Zioga E, Georgoulis AD, Bamias G, Kaliora AC. Serum Vitamins D, B9 and B12 in Greek Patients with Inflammatory Bowel Diseases. Nutrients 2020;12:E3734. [PMID: 33291539 DOI: 10.3390/nu12123734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 7 |
Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P. Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur psychiatr 2006;21:194-9. [DOI: 10.1016/j.eurpsy.2005.05.008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 8 |
Wåhlin M, Stjernman H, Munck B. Disease-Related Worries in Persons With Crohn Disease: An Interview Study. Gastroenterol Nurs 2019;42:435-42. [PMID: 31574072 DOI: 10.1097/SGA.0000000000000395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Ryan ÉJ, Orsi G, Boland MR, Syed AZ, Creavin B, Kelly ME, Sheahan K, Neary PC, Kavanagh DO, McNamara D, Winter DC, O'Riordan JM. Meta-analysis of early bowel resection versus initial medical therapy in patient's with ileocolonic Crohn's disease. Int J Colorectal Dis 2020;35:501-12. [PMID: 31915984 DOI: 10.1007/s00384-019-03479-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 10 |
Quinn CC, Chard S, Roth EG, Eckert JK, Russman KM, Cross RK. The Telemedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Clinical Trial: Qualitative Assessment of Participants' Perceptions. J Med Internet Res 2019;21:e14165. [PMID: 31162128 DOI: 10.2196/14165] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 11 |
Armuzzi A, Riegler G, Furfaro F, Baldoni M, Costa F, Fortuna M, Iaquinto G, Paese P, Papi C, Bossa F, Tontini GE, Di Fino S, Gualberti G, Merolla R, Rizzello F. Epidemiological features and disease-related concerns of a large cohort of Italian patients with active Crohn's disease. Dig Liver Dis 2019;51:804-11. [PMID: 30685416 DOI: 10.1016/j.dld.2018.12.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 12 |
López-Cortés R, Herrero-Hahn R, De la Rosa-Eduardo R, Montoya-Juárez R, García-Caro MP, Marín-Fernández B, Hueso-Montoro C. Cultural Adaptation and Validation of the Inflammatory Bowel Disease Disability Index in a Spanish Population and Its Association with Sociodemographic and Clinical Factors. Int J Environ Res Public Health 2019;16:E635. [PMID: 30795550 DOI: 10.3390/ijerph16040635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Yamada Y, Ohno Y, Niwa T, Kato-Hayashi H, Hayashi H, Ibuka T, Araki H, Sugiyama T, Shimizu M, Suzuki A. Rapid attainment of target trough concentrations of tacrolimus for early improvement of clinical symptoms in patients with ulcerative colitis. J Clin Pharm Ther. 2019;44:409-414. [PMID: 30604428 DOI: 10.1111/jcpt.12800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 14 |
Kim S, Park S, Kang Y, Kim JE, Kang B, Choe BH, Lee YJ, Park JH, Yang HR, Lee SH, Kim KM, Ryoo E, Tchah H, Shim JO, Koh H. Can We Estimate Quality of Life in Pediatric Inflammatory Bowel Disease Patients? An Asian Multicenter Study. J Pediatr Gastroenterol Nutr 2019;68:45-9. [PMID: 30052570 DOI: 10.1097/MPG.0000000000002119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
Calderón M, Minckas N, Nuñez S, Ciapponi A. Inflammatory Bowel Disease in Latin America: A Systematic Review. Value in Health Regional Issues 2018;17:126-34. [DOI: 10.1016/j.vhri.2018.03.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 16 |
Chetcuti Zammit S, Ellul P, Girardin G, Valpiani D, Nielsen KR, Olsen J, Goldis A, Lazar D, Shonová O, Nováková M, Sebastian S, Whitehead E, Carmona A, Martinez-Cadilla J, Dahlerup JF, Kievit ALH, Thorsgaard N, Katsanos KH, Christodoulou DK, Magro F, Salupere R, Pedersen N, Kjeldsen J, Carlsen K, Ioannis K, Bergemalm D, Halfvarson J, Duricova D, Bortlik M, Collin P, Oksanen P, Kiudelis G, Kupcinskas L, Kudsk K, Andersen V, O'Morain C, Bailey Y, Doron S, Shmuel O, Almer S, Arebi N, Misra R, Čuković-Čavka S, Brinar M, Munkholm P, Vegh Z, Burisch J. Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study. Eur J Gastroenterol Hepatol 2018;30:1297-303. [PMID: 30134383 DOI: 10.1097/MEG.0000000000001238] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 17 |
Gurková E, Soósová MS. Illness Cognitions and Health-Related Quality of Life of Patients With Inflammatory Bowel Disease. Gastroenterol Nurs 2018;41:29-37. [PMID: 29373353 DOI: 10.1097/SGA.0000000000000309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 18 |
Willian MK, D'Haens G, Yarlas A, Joshi AV. Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study. J Patient Rep Outcomes 2018;2:22. [PMID: 30294708 DOI: 10.1186/s41687-018-0046-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 19 |
Habibi F, Habibi ME, Gharavinia A, Mahdavi SB, Akbarpour MJ, Baghaei A, Emami MH. Quality of life in inflammatory bowel disease patients: A cross-sectional study. J Res Med Sci 2017;22:104. [PMID: 29026420 DOI: 10.4103/jrms.JRMS_975_16] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 20 |
Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, Warusavitarne J, Buskens CJ, van Bodegraven AA, Brink MA, Consten ECJ, van Wagensveld BA, Rijk MCM, Crolla RMPH, Noomen CG, Houdijk APJ, Mallant RC, Boom M, Marsman WA, Stockmann HB, Mol B, de Groof AJ, Stokkers PC, D'Haens GR, Bemelman WA; LIR!C study group. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial. Lancet Gastroenterol Hepatol 2017;2:785-92. [PMID: 28838644 DOI: 10.1016/S2468-1253(17)30248-0] [Cited by in Crossref: 127] [Cited by in F6Publishing: 111] [Article Influence: 21.2] [Reference Citation Analysis]
|
| 21 |
Sarid O, Slonim-Nevo V, Pereg A, Friger M, Sergienko R, Schwartz D, Greenberg D, Shahar I, Chernin E, Vardi H, Eidelman L, Segal A, Ben-Yakov G, Gaspar N, Munteanu D, Rozental A, Mushkalo A, Dizengof V, Abu-Freha N, Fich A, Odes S; Israeli IBD Research Nucleus (IIRN). Coping strategies, satisfaction with life, and quality of life in Crohn's disease: A gender perspective using structural equation modeling analysis. PLoS One 2017;12:e0172779. [PMID: 28245260 DOI: 10.1371/journal.pone.0172779] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 22 |
Chouliaras G, Margoni D, Dimakou K, Fessatou S, Panayiotou I, Roma-Giannikou E. Disease impact on the quality of life of children with inflammatory bowel disease. World J Gastroenterol 2017; 23(6): 1067-1075 [PMID: 28246481 DOI: 10.3748/wjg.v23.i6.1067] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 23 |
Tsoukka M, Jelastopulu E, Lavranos G, Charalambous G. Estimation of quality of life in Cypriot patients with inflammatory bowel disease. World J Gastroenterol 2017; 23(1): 121-126 [PMID: 28104987 DOI: 10.3748/wjg.v23.i1.121] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Khanna R, Feagan BG. Evaluation of Health Economics in Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2017. [DOI: 10.1007/978-3-319-33703-6_26] [Reference Citation Analysis]
|
| 25 |
Tribbick D, Salzberg M, Connell W, Macrae F, Kamm M, Bates G, Cunningham G, Austin D, Knowles S. Differences Across Illness Perceptions in Inflammatory Bowel Disease and Their Relationships to Psychological Distress and Quality of Life. Gastroenterol Nurs 2017;40:291-9. [PMID: 28746114 DOI: 10.1097/SGA.0000000000000225] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Holdam AS, Bager P, Dahlerup JF. Biological therapy increases the health-related quality of life in patients with inflammatory bowel disease in a clinical setting. Scand J Gastroenterol 2016;51:706-11. [PMID: 26794211 DOI: 10.3109/00365521.2015.1136352] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 27 |
Huppertz-Hauss G, Aas E, Lie Høivik M, Langholz E, Odes S, Småstuen M, Stockbrugger R, Hoff G, Moum B, Bernklev T. Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis. Gastroenterol Res Pract 2016;2016:5023973. [PMID: 27630711 DOI: 10.1155/2016/5023973] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 28 |
Zhao X, Li N, Ren Y, Ma T, Wang C, Wang J, You S. Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0160500. [PMID: 27501314 DOI: 10.1371/journal.pone.0160500] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 29 |
Jelsness-Jørgensen LP, Bernklev T, Moum B. Coexisting irritable bowel-like symptoms in inflammatory bowel disease in remission is associated with impaired social functioning and increased bodily pain. Gastroenterol Nurs. 2014;37:280-287. [PMID: 25078042 DOI: 10.1097/SGA.0000000000000055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 30 |
Huppertz-Hauss G, Lie Høivik M, Jelsness-Jørgensen LP, Henriksen M, Høie O, Jahnsen J, Hoff G, Moum B, Bernklev T. Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study. Inflamm Bowel Dis 2016;22:1679-87. [PMID: 27206016 DOI: 10.1097/MIB.0000000000000806] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 31 |
Vogelaar L, van den Berg-Emons R, Bussmann H, Rozenberg R, Timman R, van der Woude CJ. Physical fitness and physical activity in fatigued and non-fatigued inflammatory bowel disease patients. Scand J Gastroenterol 2015;50:1357-67. [PMID: 25966749 DOI: 10.3109/00365521.2015.1046135] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 32 |
Bilski J, Mazur-Bialy A, Brzozowski B, Magierowski M, Zahradnik-Bilska J, Wójcik D, Magierowska K, Kwiecien S, Mach T, Brzozowski T. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence. Pharmacol Rep 2016;68:827-36. [PMID: 27255494 DOI: 10.1016/j.pharep.2016.04.009] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 33 |
Gerbarg PL, Jacob VE, Stevens L, Bosworth BP, Chabouni F, DeFilippis EM, Warren R, Trivellas M, Patel PV, Webb CD, Harbus MD, Christos PJ, Brown RP, Scherl EJ. The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial. Inflamm Bowel Dis 2015;21:2886-96. [PMID: 26426148 DOI: 10.1097/MIB.0000000000000568] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 34 |
Del Pinto R, Pietropaoli D, Chandar AK, Ferri C, Cominelli F. Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis. Inflamm Bowel Dis 2015;21:2708-17. [PMID: 26348447 DOI: 10.1097/MIB.0000000000000546] [Cited by in Crossref: 148] [Cited by in F6Publishing: 139] [Article Influence: 18.5] [Reference Citation Analysis]
|
| 35 |
Theede K, Kiszka-Kanowitz M, Nordgaard-Lassen I, Mertz Nielsen A. The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients. J Crohns Colitis 2015;9:625-32. [PMID: 25956537 DOI: 10.1093/ecco-jcc/jjv081] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 36 |
Faus AL, Turchi RM, Polansky M, Berez A, Leibowitz KL. Health-Related Quality of Life in Overweight/Obese Children Compared With Children With Inflammatory Bowel Disease. Clin Pediatr (Phila) 2015;54:775-82. [PMID: 25520367 DOI: 10.1177/0009922814562555] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 37 |
Sammut J, Scerri J, Xuereb RB. The lived experience of adults with ulcerative colitis. J Clin Nurs 2015;24:2659-67. [PMID: 26111098 DOI: 10.1111/jocn.12892] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 38 |
Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Sparrow MP, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond PV. Effect of intestinal resection on quality of life in Crohn's disease. J Crohns Colitis 2015;9:452-62. [PMID: 25855073 DOI: 10.1093/ecco-jcc/jjv058] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 39 |
Björnsson ES, Ekbom A. Scandinavian epidemiological research in gastroenterology and hepatology. Scand J Gastroenterol 2015;50:636-48. [PMID: 25881666 DOI: 10.3109/00365521.2015.1034168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 40 |
Raszeja-Wyszomirska J, Wunsch E, Krawczyk M, Rigopoulou EI, Bogdanos D, Milkiewicz P. Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis. Liver Int 2015;35:1764-71. [PMID: 25388280 DOI: 10.1111/liv.12730] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 41 |
Wright EK, Kamm MA. Impact of drug therapy and surgery on quality of life in Crohn's disease: a systematic review. Inflamm Bowel Dis 2015;21:1187-94. [PMID: 25895008 DOI: 10.1097/MIB.0000000000000271] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 42 |
Zheng K, Zhang S, Wang C, Zhao W, Shen H. Health-related quality of life in Chinese patients with mild and moderately active ulcerative colitis. PLoS One 2015;10:e0124211. [PMID: 25915777 DOI: 10.1371/journal.pone.0124211] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 43 |
Huppertz-Hauss G, Høivik ML, Langholz E, Odes S, Småstuen M, Stockbrugger R, Hoff G, Moum B, Bernklev T. Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis. Inflamm Bowel Dis 2015;21:337-44. [PMID: 25569735 DOI: 10.1097/MIB.0000000000000272] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 44 |
Gotthardt DN, Rupp C, Bruhin M, Schellberg D, Weiss KH, Stefan R, Donnerstag N, Stremmel W, Löwe B, Juenger J, Sauer P. Pruritus is associated with severely impaired quality of life in patients with primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 2014;26:1374-9. [PMID: 25341059 DOI: 10.1097/MEG.0000000000000223] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 45 |
Yarlas A, Yen L, Hodgkins P. The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamine. Qual Life Res 2015;24:671-83. [PMID: 25193617 DOI: 10.1007/s11136-014-0797-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 46 |
Burisch J, Weimers P, Pedersen N, Cukovic-Cavka S, Vucelic B, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Ragnarsson G, Björnsson E, Bailey Y, O'Morain C, Schwartz D, Odes S, Valpiani D, Boni MC, Jonaitis L, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Sanroman L, Almer S, Zhulina Y, Halfvarson J, Arebi N, Diggory T, Sebastian S, Lakatos PL, Langholz E, Munkholm P; EpiCom-group. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study. J Crohns Colitis 2014;8:1030-42. [PMID: 24560877 DOI: 10.1016/j.crohns.2014.01.028] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 47 |
Cohen BL, Zoëga H, Shah SA, Leleiko N, Lidofsky S, Bright R, Flowers N, Law M, Moniz H, Merrick M, Sands BE. Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity. Aliment Pharmacol Ther 2014;39:811-22. [PMID: 24612278 DOI: 10.1111/apt.12659] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 48 |
Yuge K, Takahashi T, Khai NC, Goto K, Fujiwara T, Fujiwara H, Kosai K. Intramuscular injection of adenoviral hepatocyte growth factor at a distal site ameliorates dextran sodium sulfate-induced colitis in mice. Int J Mol Med 2014;33:1064-74. [PMID: 24604303 DOI: 10.3892/ijmm.2014.1686] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 49 |
van der Have M, van der Aalst KS, Kaptein AA, Leenders M, Siersema PD, Oldenburg B, Fidder HH. Determinants of health-related quality of life in Crohn's disease: a systematic review and meta-analysis. J Crohns Colitis 2014;8:93-106. [PMID: 23746864 DOI: 10.1016/j.crohns.2013.04.007] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 50 |
Opheim R, Fagermoen MS, Jelsness-Jørgensen LP, Bernklev T, Moum B. Sense of coherence in patients with inflammatory bowel disease. Gastroenterol Res Pract. 2014;2014:989038. [PMID: 24527028 DOI: 10.1155/2014/989038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 51 |
Iglesias-Rey M, Barreiro-de Acosta M, Caamaño-Isorna F, Rodríguez IV, Ferreiro R, Lindkvist B, González AL, Dominguez-Munoz JE. Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis 2014;20:92-102. [PMID: 24193152 DOI: 10.1097/01.MIB.0000436955.78220.bc] [Cited by in Crossref: 15] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 52 |
Gumidyala AP, Greenley RN. Correlates of Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease: A Cumulative Risk Model Approach. Journal of Pediatric Psychology 2014;39:55-64. [DOI: 10.1093/jpepsy/jst073] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 53 |
Schreiber S, Panés J, Louis E, Holley D, Buch M, Paridaens K. National differences in ulcerative colitis experience and management among patients from five European countries and Canada: an online survey. J Crohns Colitis 2013;7:497-509. [PMID: 22921464 DOI: 10.1016/j.crohns.2012.07.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 54 |
Jaghult S, Saboonchi F, Moller J, Johansson UB, Wredling R, Kapraali M. Stress as a Trigger for Relapses in IBD: A Case-Crossover Study. Gastroenterology Res 2013;6:10-6. [PMID: 27785220 DOI: 10.4021/gr528e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 55 |
Rocchi A, Benchimol EI, Bernstein CN, Bitton A, Feagan B, Panaccione R, Glasgow KW, Fernandes A, Ghosh S. Inflammatory bowel disease: a Canadian burden of illness review. Can J Gastroenterol. 2012;26:811-817. [PMID: 23166905 DOI: 10.1155/2012/984575] [Cited by in Crossref: 174] [Cited by in F6Publishing: 194] [Article Influence: 17.4] [Reference Citation Analysis]
|
| 56 |
Hodgkins P, Yen L, Yarlas A, Karlstadt R, Solomon D, Kane S. Impact of MMX® mesalamine on improvement and maintenance of health-related quality of life in patients with ulcerative colitis. Inflamm Bowel Dis 2013;19:386-96. [PMID: 22648999 DOI: 10.1002/ibd.23022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 57 |
Nurmi E, Haapamäki J, Paavilainen E, Rantanen A, Hillilä M, Arkkila P. The burden of inflammatory bowel disease on health care utilization and quality of life. Scand J Gastroenterol 2013;48:51-7. [PMID: 22577851 DOI: 10.3109/00365521.2012.685750] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 58 |
Horváth G, Farkas K, Hollósi R, Nagy F, Szepes Z, Papp M, Palatka K, Miheller P, Lakatos L, Szamosi T, Nyári T, Wittmann T, Molnár T. Is there any association between impaired health-related quality of life and non-adherence to medical therapy in inflammatory bowel disease? Scand J Gastroenterol 2012;47:1298-303. [PMID: 22935014 DOI: 10.3109/00365521.2012.703233] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 59 |
Schreiber S, Panés J, Louis E, Holley D, Buch M, Paridaens K. Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey. BMC Gastroenterol 2012;12:108. [PMID: 22894661 DOI: 10.1186/1471-230X-12-108] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 60 |
Hoivik ML, Moum B, Solberg IC, Cvancarova M, Hoie O, Vatn MH, Bernklev T; IBSEN Study Group. Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study. Inflamm Bowel Dis 2012;18:1540-9. [PMID: 21936030 DOI: 10.1002/ibd.21863] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 61 |
Lesuis N, Befrits R, Nyberg F, van Vollenhoven RF. Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study. BMC Med 2012;10:82. [PMID: 22853635 DOI: 10.1186/1741-7015-10-82] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 62 |
Marsh AM, Lobo AJ. Commentary: impact of MMX mesalazine on health-related quality of life in ulcerative colitis. Aliment Pharmacol Ther 2012;36:402. [PMID: 22803649 DOI: 10.1111/j.1365-2036.2012.05190.x] [Reference Citation Analysis]
|
| 63 |
Dudley-Brown S, Baker K. Ulcerative colitis from patients' viewpoint: a review of two Internet surveys. Gastroenterol Nurs 2012;35:54-63. [PMID: 22306730 DOI: 10.1097/SGA.0b013e318241d981] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 64 |
Solomon D, Yarlas A, Hodgkins P, Karlstadt R, Yen L, Kane S. The impact of MMX mesalazine on disease-specific health-related quality of life in ulcerative colitis patients. Aliment Pharmacol Ther 2012;35:1386-96. [PMID: 22536781 DOI: 10.1111/j.1365-2036.2012.05107.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 65 |
Høivik ML, Bernklev T, Solberg IC, Cvancarova M, Lygren I, Jahnsen J, Moum B; IBSEN Study Group. Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study. J Crohns Colitis 2012;6:441-53. [PMID: 22398064 DOI: 10.1016/j.crohns.2011.10.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 66 |
Opheim R, Hoivik ML, Solberg IC, Moum B; IBSEN Study Group. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN). J Crohns Colitis 2012;6:345-53. [PMID: 22405172 DOI: 10.1016/j.crohns.2011.09.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 67 |
Jelsness-Jørgensen LP, Bernklev T, Moum B. Quality of life in patients with inflammatory bowel disease: translation, validity, reliability and sensitivity to change of the Norwegian version of the short health scale (SHS). Qual Life Res 2012;21:1671-6. [PMID: 22146840 DOI: 10.1007/s11136-011-0081-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 68 |
Vogelaar L, Van't Spijker A, Vogelaar T, van Busschbach JJ, Visser MS, Kuipers EJ, van der Woude CJ. Solution focused therapy: a promising new tool in the management of fatigue in Crohn's disease patients psychological interventions for the management of fatigue in Crohn's disease. J Crohns Colitis 2011;5:585-91. [PMID: 22115379 DOI: 10.1016/j.crohns.2011.06.001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 69 |
Marant C, Arnould B, Marrel A, Spizak C, Colombel JF, Faure P, Hagege H, Lemann M, Nahon S, Tucat G, Vandromme L, Thibout E, Goldfarb G. Assessing patients' satisfaction with anti-TNFα treatment in Crohn's disease: qualitative steps of the development of a new questionnaire. Clin Exp Gastroenterol 2011;4:173-80. [PMID: 21904463 DOI: 10.2147/CEG.S18585] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 70 |
Jelsness-Jørgensen LP, Moum B, Bernklev T. Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year. Gastroenterol Res Pract 2011;2011:492034. [PMID: 21912537 DOI: 10.1155/2011/492034] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 71 |
Jelsness-Jørgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis 2011;17:1564-72. [PMID: 21674713 DOI: 10.1002/ibd.21530] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 72 |
Prasko J, Jelenova D, Mihal V. Psychological aspects and psychotherapy of inflammatory bowel diseases and irritable bowel syndrome in children. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010;154:307-14. [PMID: 21293541 DOI: 10.5507/bp.2010.046] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 73 |
Jäghult S, Saboonchi F, Johansson UB, Wredling R, Kapraali M. Identifying predictors of low health-related quality of life among patients with inflammatory bowel disease: comparison between Crohn's disease and ulcerative colitis with disease duration. J Clin Nurs 2011;20:1578-87. [PMID: 21418363 DOI: 10.1111/j.1365-2702.2010.03614.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 74 |
Farrell D, Savage E. Symptom burden in inflammatory bowel disease: rethinking conceptual and theoretical underpinnings. Int J Nurs Pract 2010;16:437-42. [PMID: 20854340 DOI: 10.1111/j.1440-172X.2010.01867.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 75 |
Jelsness-Jørgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA. Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther 2011;33:106-14. [PMID: 21083587 DOI: 10.1111/j.1365-2036.2010.04498.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 76 |
Romberg-Camps MJ, Bol Y, Dagnelie PC, Hesselink-van de Kruijs MA, Kester AD, Engels LG, van Deursen C, Hameeteman WH, Pierik M, Wolters F, Russel MG, Stockbrügger RW. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 2010;16:2137-47. [PMID: 20848468 DOI: 10.1002/ibd.21285] [Cited by in Crossref: 155] [Cited by in F6Publishing: 132] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 77 |
Jaghult S, Saboonchi F, Johansson UB, Wredling R, Kapraali M. Factor structures of the Swedish Version of the RFIPC: Investigating the Validity of Measurements of IBD Patients' Worries and Concerns. Gastroenterology Res 2010;3:191-200. [PMID: 27956996 DOI: 10.4021/gr247w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 78 |
Elkjaer M, Burisch J, Avnstrøm S, Lynge E, Munkholm P. Development of a Web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment. Eur J Gastroenterol Hepatol 2010;22:695-704. [PMID: 19543101 DOI: 10.1097/MEG.0b013e32832e0a18] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 79 |
Rubin DT, Dubinsky MC, Panaccione R, Siegel CA, Binion DG, Kane SV, Hopper J. The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey. Dig Dis Sci 2010;55:1044-52. [PMID: 20155319 DOI: 10.1007/s10620-009-0953-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 80 |
Ananthakrishnan AN, Beaulieu DB, Ulitsky A, Zadvornova Y, Skaros S, Johnson K, Naik A, Perera L, Issa M, Binion DG, Saeian K. Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease? Inflamm Bowel Dis 2010;16:494-500. [PMID: 19637332 DOI: 10.1002/ibd.21051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 81 |
Hoivik ML, Bernklev T, Moum B. Need for standardization in population-based quality of life studies: a review of the current literature. Inflamm Bowel Dis 2010;16:525-36. [PMID: 19637337 DOI: 10.1002/ibd.21032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 82 |
Prantera C, Kohn A, Campieri M, Caprilli R, Cottone M, Pallone F, Savarino V, Sturniolo GC, Vecchi M, Ardia A, Bellinvia S. Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol. Aliment Pharmacol Ther 2009;30:908-18. [PMID: 19678813 DOI: 10.1111/j.1365-2036.2009.04117.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 83 |
Vogelaar L, Spijker AV, van der Woude CJ. The impact of biologics on health-related quality of life in patients with inflammatory bowel disease. Clin Exp Gastroenterol. 2009;2:101-109. [PMID: 21694833 DOI: 10.2147/ceg.s4512] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 84 |
Feagan BG, Coteur G, Tan S, Keininger DL, Schreiber S. Clinically meaningful improvement in health-related quality of life in a randomized controlled trial of certolizumab pegol maintenance therapy for Crohn's disease. Am J Gastroenterol 2009;104:1976-83. [PMID: 19471252 DOI: 10.1038/ajg.2009.199] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 85 |
Haapamäki J, Turunen U, Roine RP, Färkkilä MA, Arkkila PE. Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease. Qual Life Res 2009;18:961-9. [PMID: 19629750 DOI: 10.1007/s11136-009-9514-y] [Reference Citation Analysis]
|
| 86 |
Haapamäki J, Turunen U, Roine RP, Färkkilä MA, Arkkila PET. Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease. Qual Life Res 2009;18:961-9. [DOI: 10.1007/s11136-009-9514-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 87 |
Munson GW, Wallston KA, Dittus RS, Speroff T, Roumie CL. Activation and perceived expectancies: correlations with health outcomes among veterans with inflammatory bowel disease. J Gen Intern Med 2009;24:809-15. [PMID: 19444526 DOI: 10.1007/s11606-009-1002-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 88 |
Rubin DT, Siegel CA, Kane SV, Binion DG, Panaccione R, Dubinsky MC, Loftus EV, Hopper J. Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey. Inflamm Bowel Dis 2009;15:581-8. [PMID: 19067414 DOI: 10.1002/ibd.20793] [Cited by in Crossref: 75] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 89 |
Boye B, Lundin KE, Leganger S, Mokleby K, Jantschek G, Jantschek I, Kunzendorf S, Benninghoven D, Sharpe M, Wilhelmsen I, Blomhoff S, Malt UF, Jahnsen J. The INSPIRE study: do personality traits predict general quality of life (Short form-36) in distressed patients with ulcerative colitis and Crohn's disease? Scand J Gastroenterol 2008;43:1505-13. [PMID: 18777439 DOI: 10.1080/00365520802321196] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 90 |
Tindall WN. New approaches to adherence issues when dosing oral aminosalicylates in ulcerative colitis. American Journal of Health-System Pharmacy 2009;66:451-7. [DOI: 10.2146/ajhp070442] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 91 |
Deter HC, von Wietersheim J, Jantschek G, Burgdorf F, Blum B, Keller W. High-utilizing Crohn's disease patients under psychosomatic therapy. Biopsychosoc Med. 2008;2:18. [PMID: 18851749 DOI: 10.1186/1751-0759-2-18] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 92 |
Caprilli R, Angelucci E, Clemente V. Recent advances in the management of Crohn's disease. Dig Liver Dis 2008;40:709-16. [PMID: 18430617 DOI: 10.1016/j.dld.2008.02.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 93 |
Kamm MA, Lichtenstein GR, Sandborn WJ, Schreiber S, Lees K, Barrett K, Joseph R. Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis. Gut 2008;57:893-902. [PMID: 18272546 DOI: 10.1136/gut.2007.138248] [Cited by in Crossref: 118] [Cited by in F6Publishing: 131] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 94 |
Kuriyama M, Kato J, Kuwaki K, Morimoto N, Nawa T, Fujimoto T, Kono H, Okano N, Miyaike J, Morita T, Okada H, Suzuki S, Yoshioka T, Shiode J, Suwaki K, Sakaguchi K, Shiratori Y; Japan West Ulcerative Colitis Study Group. Clinical factors that impair health-related quality of life in ulcerative colitis patients vary with the disease duration. Eur J Gastroenterol Hepatol 2008;20:634-41. [PMID: 18679065 DOI: 10.1097/MEG.0b013e3282f5e9c9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 95 |
Cohen R, Robinson D Jr, Paramore C, Fraeman K, Renahan K, Bala M. Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002. Inflamm Bowel Dis 2008;14:738-43. [PMID: 18300281 DOI: 10.1002/ibd.20406] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 96 |
Elkjaer M, Moser G, Reinisch W, Durovicova D, Lukas M, Vucelic B, Wewer V, Frederic Colombel J, Shuhaibar M, O'Morain C, Politi P, Odes S, Bernklev T, Oresland T, Nikulina I, Belousova E, Van der Eijk I, Munkholm P. IBD patients need in health quality of care ECCO consensus. J Crohns Colitis 2008;2:181-8. [PMID: 21172209 DOI: 10.1016/j.crohns.2008.02.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 97 |
Schreiber S, Kamm MA, Lichtenstein GR. Mesalamine with MMX technology for the treatment of ulcerative colitis. Expert Rev Gastroenterol Hepatol 2008;2:299-314. [PMID: 19072380 DOI: 10.1586/17474124.2.3.299] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 98 |
Boye B, Jahnsen J, Mokleby K, Leganger S, Jantschek G, Jantschek I, Kunzendorf S, Benninghoven D, Wilhelmsen I, Sharpe M, Blomhoff S, Malt UF, Lundin KE. The INSPIRE study: are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease? Inflamm Bowel Dis 2008;14:680-6. [PMID: 18509900 DOI: 10.1002/ibd.20367] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 99 |
Irvine EJ. Quality of life of patients with ulcerative colitis: past, present, and future. Inflamm Bowel Dis 2008;14:554-65. [PMID: 17973299 DOI: 10.1002/ibd.20301] [Cited by in Crossref: 92] [Cited by in F6Publishing: 81] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 100 |
Boye B, Jahnsen J, Lundin KEA, Wilhelmsen I, Malt UF, Jantschek G. Chronisch entzündliche Darmerkrankungen (Colitis ulcerosa und Morbus Crohn) aus der Perspektive der Konsiliar-/Liaison-Psychosomatik und -Psychiatrie. Psychosom Konsiliarpsychiatr 2007;1:258-265. [DOI: 10.1007/s11800-007-0026-8] [Reference Citation Analysis]
|
| 101 |
Dinesen L, Travis S. Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870). Int J Nanomedicine 2007;2:39-47. [PMID: 17722511 DOI: 10.2147/nano.2007.2.1.39] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 102 |
Höie O, Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T, Odes S, Mouzas IA, Beltrami M, Langholz E, Stockbrügger R, Vatn M, Moum B; European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD). Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 2007;102:1692-701. [PMID: 17555460 DOI: 10.1111/j.1572-0241.2007.01265.x] [Cited by in Crossref: 158] [Cited by in F6Publishing: 158] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 103 |
Deter HC, Keller W, von Wietersheim J, Jantschek G, Duchmann R, Zeitz M; German Study Group on Psychosocial Intervention in Crohn's Disease. Psychological treatment may reduce the need for healthcare in patients with Crohn's disease. Inflamm Bowel Dis 2007;13:745-52. [PMID: 17230495 DOI: 10.1002/ibd.20068] [Cited by in Crossref: 59] [Cited by in F6Publishing: 106] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 104 |
Langhorst J, Mueller T, Luedtke R, Franken U, Paul A, Michalsen A, Schedlowski M, Dobos GJ, Elsenbruch S. Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up. Scand J Gastroenterol 2007;42:734-45. [PMID: 17505996 DOI: 10.1080/00365520601101682] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 105 |
Höie O, Schouten LJ, Wolters FL, Solberg IC, Riis L, Mouzas IA, Politi P, Odes S, Langholz E, Vatn M, Stockbrügger RW, Moum B; European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD). Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut 2007;56:497-503. [PMID: 17028127 DOI: 10.1136/gut.2006.101519] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 106 |
Houdeau E, Moriez R, Leveque M, Salvador-Cartier C, Waget A, Leng L, Bueno L, Bucala R, Fioramonti J. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat. Gastroenterology 2007;132:982-93. [PMID: 17324399 DOI: 10.1053/j.gastro.2006.12.028] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 107 |
Hoie O, Wolters FL, Riis L, Bernklev T, Aamodt G, Clofent J, Tsianos E, Beltrami M, Odes S, Munkholm P, Vatn M, Stockbrügger RW, Moum B; European Collaborative Study Group of Inflammatory Bowel Disease. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007;132:507-15. [PMID: 17258717 DOI: 10.1053/j.gastro.2006.11.015] [Cited by in Crossref: 198] [Cited by in F6Publishing: 209] [Article Influence: 12.4] [Reference Citation Analysis]
|
| 108 |
von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis 2006;12:1175-84. [PMID: 17119392 DOI: 10.1097/01.mib.0000236925.87502.e0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 109 |
Loftus EV Jr. A practical perspective on ulcerative colitis: patients' needs from aminosalicylate therapies. Inflamm Bowel Dis 2006;12:1107-13. [PMID: 17119384 DOI: 10.1097/01.mib.0000235831.01682.8d] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 110 |
Leung Y, Geddes M, Storek J, Panaccione R, Beck P. Hematopoietic cell transplantation for Crohn’s disease; is it time? World J Gastroenterol 2006; 12(41): 6665-6673 [PMID: 17075981 DOI: 10.3748/wjg.v12.i41.6665] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 111 |
Dekkers OM, van der Klaauw AA, Pereira AM, Biermasz NR, Honkoop PJ, Roelfsema F, Smit JW, Romijn JA. Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 2006;91:3364-9. [PMID: 16787991 DOI: 10.1210/jc.2006-0003] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 112 |
Otley AR, Griffiths AM, Hale S, Kugathasan S, Pfefferkorn M, Mezoff A, Rosh J, Tolia V, Markowitz J, Mack D, Oliva-Hemker M, Wyllie R, Rothbaum R, Bousvaros A, Del Rosario JF, Evans J, Blanchard W, Hyams J; Pediatric IBD Collaborative Research Group. Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006;12:684-91. [PMID: 16917222 DOI: 10.1097/00054725-200608000-00003] [Cited by in Crossref: 79] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 113 |
Bernklev T, Jahnsen J, Henriksen M, Lygren I, Aadland E, Sauar J, Schulz T, Stray N, Vatn M, Moum B. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006;12:402-12. [PMID: 16670530 DOI: 10.1097/01.MIB.0000218762.61217.4a] [Cited by in Crossref: 144] [Cited by in F6Publishing: 108] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 114 |
Dekkers OM, Biermasz NR, Smit JW, Groot LE, Roelfsema F, Romijn JA, Pereira AM. Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol 2006;154:483-9. [PMID: 16498063 DOI: 10.1530/eje.1.02114] [Cited by in Crossref: 77] [Cited by in F6Publishing: 81] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 115 |
Casellas F, Vivancos JL, Sampedro M, Malagelada JR. Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life. Am J Gastroenterol 2005;100:2737-42. [PMID: 16393228 DOI: 10.1111/j.1572-0241.2005.00360.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 116 |
Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M, Moum B. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis 2005;11:909-18. [PMID: 16189421 DOI: 10.1097/01.mib.0000179467.01748.99] [Cited by in Crossref: 160] [Cited by in F6Publishing: 127] [Article Influence: 8.9] [Reference Citation Analysis]
|
| 117 |
Sainsbury A, Heatley RV. Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005;21:499-508. [PMID: 15740531 DOI: 10.1111/j.1365-2036.2005.02380.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 82] [Article Influence: 5.6] [Reference Citation Analysis]
|
